Antibody-drug conjugates: fundamentals, drug development, and clinical outcomes to target cancer
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Hoboken, New Jersey
John Wiley & Sons, Incorporated
[2017]
|
| Subjects: | |
| Item Description: | Description based on print version record |
| Physical Description: | 1 online resource (566 pages) color illustrations |
| ISBN: | 9781119060802 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045254484 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 181026s2017 |||| o||u| ||||||eng d | ||
| 020 | |a 9781119060802 |c ebook |9 978-1-119-06080-2 | ||
| 035 | |a (ZDB-30-PAD)EBC4745624 | ||
| 035 | |a (ZDB-89-EBL)EBL4745624 | ||
| 035 | |a (ZDB-38-EBR)ebr11300198 | ||
| 035 | |a (OCoLC)964410742 | ||
| 035 | |a (DE-599)BVBBV045254484 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.7/98 |2 23 | |
| 084 | |a VS 9400 |0 (DE-625)147728:253 |2 rvk | ||
| 130 | 0 | |a Antibody-drug conjugates (Olivier) | |
| 245 | 1 | 0 | |a Antibody-drug conjugates |b fundamentals, drug development, and clinical outcomes to target cancer |c edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz |
| 264 | 1 | |a Hoboken, New Jersey |b John Wiley & Sons, Incorporated |c [2017] | |
| 264 | 4 | |c © 2017 | |
| 300 | |a 1 online resource (566 pages) |b color illustrations | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Description based on print version record | ||
| 650 | 4 | |a Antibody-toxin conjugates | |
| 650 | 4 | |a Monoclonal antibodies | |
| 650 | 4 | |a Antineoplastic agents | |
| 650 | 4 | |a Tumors |x Treatment | |
| 700 | 1 | |a Olivier, Kenneth J. |c Jr. |d 1968- |4 edt | |
| 700 | 1 | |a Hurvitz, Sara A. |d 1970- |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Antibody-drug conjugates (Olivier) |t Antibody-drug conjugates : fundamentals, drug development, and clinical outcomes to target cancer |d Hoboken, New Jersey : John Wiley & Sons, Incorporated, [2017] |z 9781119060680 |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030642460 | ||
Record in the Search Index
| _version_ | 1804179001688719360 |
|---|---|
| any_adam_object | |
| author2 | Olivier, Kenneth J. Jr. 1968- Hurvitz, Sara A. 1970- |
| author2_role | edt edt |
| author2_variant | k j o kj kjo s a h sa sah |
| author_facet | Olivier, Kenneth J. Jr. 1968- Hurvitz, Sara A. 1970- |
| building | Verbundindex |
| bvnumber | BV045254484 |
| classification_rvk | VS 9400 |
| collection | ZDB-30-PAD |
| ctrlnum | (ZDB-30-PAD)EBC4745624 (ZDB-89-EBL)EBL4745624 (ZDB-38-EBR)ebr11300198 (OCoLC)964410742 (DE-599)BVBBV045254484 |
| dewey-full | 615.7/98 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.7/98 |
| dewey-search | 615.7/98 |
| dewey-sort | 3615.7 298 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01683nmm a2200421zc 4500</leader><controlfield tag="001">BV045254484</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181026s2017 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781119060802</subfield><subfield code="c">ebook</subfield><subfield code="9">978-1-119-06080-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC4745624</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL4745624</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-EBR)ebr11300198</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)964410742</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045254484</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7/98</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9400</subfield><subfield code="0">(DE-625)147728:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="130" ind1="0" ind2=" "><subfield code="a">Antibody-drug conjugates (Olivier)</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibody-drug conjugates</subfield><subfield code="b">fundamentals, drug development, and clinical outcomes to target cancer</subfield><subfield code="c">edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, New Jersey</subfield><subfield code="b">John Wiley & Sons, Incorporated</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (566 pages)</subfield><subfield code="b">color illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on print version record</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibody-toxin conjugates</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoclonal antibodies</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumors</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Olivier, Kenneth J.</subfield><subfield code="c">Jr.</subfield><subfield code="d">1968-</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hurvitz, Sara A.</subfield><subfield code="d">1970-</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Antibody-drug conjugates (Olivier)</subfield><subfield code="t">Antibody-drug conjugates : fundamentals, drug development, and clinical outcomes to target cancer</subfield><subfield code="d">Hoboken, New Jersey : John Wiley & Sons, Incorporated, [2017]</subfield><subfield code="z">9781119060680</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030642460</subfield></datafield></record></collection> |
| id | DE-604.BV045254484 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T08:12:56Z |
| institution | BVB |
| isbn | 9781119060802 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030642460 |
| oclc_num | 964410742 |
| open_access_boolean | |
| physical | 1 online resource (566 pages) color illustrations |
| psigel | ZDB-30-PAD |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | John Wiley & Sons, Incorporated |
| record_format | marc |
| spelling | Antibody-drug conjugates (Olivier) Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz Hoboken, New Jersey John Wiley & Sons, Incorporated [2017] © 2017 1 online resource (566 pages) color illustrations txt rdacontent c rdamedia cr rdacarrier Description based on print version record Antibody-toxin conjugates Monoclonal antibodies Antineoplastic agents Tumors Treatment Olivier, Kenneth J. Jr. 1968- edt Hurvitz, Sara A. 1970- edt Erscheint auch als Druck-Ausgabe Antibody-drug conjugates (Olivier) Antibody-drug conjugates : fundamentals, drug development, and clinical outcomes to target cancer Hoboken, New Jersey : John Wiley & Sons, Incorporated, [2017] 9781119060680 |
| spellingShingle | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer Antibody-toxin conjugates Monoclonal antibodies Antineoplastic agents Tumors Treatment |
| title | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer |
| title_alt | Antibody-drug conjugates (Olivier) |
| title_auth | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer |
| title_exact_search | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer |
| title_full | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz |
| title_fullStr | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz |
| title_full_unstemmed | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz |
| title_short | Antibody-drug conjugates |
| title_sort | antibody drug conjugates fundamentals drug development and clinical outcomes to target cancer |
| title_sub | fundamentals, drug development, and clinical outcomes to target cancer |
| topic | Antibody-toxin conjugates Monoclonal antibodies Antineoplastic agents Tumors Treatment |
| topic_facet | Antibody-toxin conjugates Monoclonal antibodies Antineoplastic agents Tumors Treatment |
| work_keys_str_mv | UT antibodydrugconjugatesolivier AT olivierkennethj antibodydrugconjugatesfundamentalsdrugdevelopmentandclinicaloutcomestotargetcancer AT hurvitzsaraa antibodydrugconjugatesfundamentalsdrugdevelopmentandclinicaloutcomestotargetcancer |